DULOXETINE HYDROCHLORIDE

DULOXETINE HYDROCHLORIDE was reported 71546 times

DULOXETINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BRONCHIAL NEOPLASM 46 0.3382
1 NASAL TURBINATE HYPERTROPHY 76 0.2016
2 PULMONARY MALFORMATION 61 0.1738
3 POST CHOLECYSTECTOMY SYNDROME 49 0.1731
4 DELUSION OF GRANDEUR 70 0.1559
5 BRONCHIAL HAEMORRHAGE 46 0.1474
6 ENDOMETRIAL ABLATION 46 0.1289
7 GRANULOCYTE COUNT INCREASED 50 0.1235
8 REVERSIBLE AIRWAYS OBSTRUCTION 53 0.1043
9 BLOOD IMMUNOGLOBULIN A INCREASED 51 0.0946
10 ELECTRIC SHOCK 67 0.0782
11 MYOFASCIAL PAIN SYNDROME 53 0.0745
12 VITAMIN B12 INCREASED 58 0.0728
13 DACTYLITIS 66 0.0672
14 MULTIPLE DRUG THERAPY 49 0.0650
15 SOMATIC SYMPTOM DISORDER 67 0.0620
16 GLOMERULAR FILTRATION RATE INCREASED 51 0.0617
17 ELECTRIC SHOCK SENSATION 171 0.0610
18 SEROTONIN SYNDROME 1153 0.0600
19 RHEUMATOID FACTOR INCREASED 64 0.0573
20 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 103 0.0521
21 LYMPHOCYTE COUNT ABNORMAL 56 0.0497
22 JOINT NOISE 90 0.0458
23 BEZOAR 63 0.0457
24 PRODUCT USED FOR UNKNOWN INDICATION 54 0.0429
25 SUSPECTED SUICIDE 182 0.0388
26 INTERVERTEBRAL DISCITIS 72 0.0382
27 CLONUS 102 0.0372
28 RHONCHI 49 0.0355
29 HYPERREFLEXIA 122 0.0350
30 PRODUCT MONITORING ERROR 50 0.0346
31 COLITIS MICROSCOPIC 157 0.0331
32 ANXIETY DISORDER 109 0.0326
33 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 321 0.0312
34 GENITAL PAIN 46 0.0311
35 HYPERPARATHYROIDISM SECONDARY 77 0.0307
36 AFFECTIVE DISORDER 234 0.0297
37 RESPIRATORY DISORDER NEONATAL 48 0.0296
38 BRONCHIAL DISORDER 46 0.0296
39 SEDATION 745 0.0284
40 WHITE BLOOD CELLS URINE POSITIVE 52 0.0276
41 CLEFT PALATE 53 0.0274
42 REBOUND ACID HYPERSECRETION 82 0.0271
43 COMPLETED SUICIDE 2231 0.0267
44 VITAMIN B12 DECREASED 77 0.0267
45 COMA SCALE ABNORMAL 76 0.0262
46 PERSONALITY DISORDER 68 0.0259
47 NEPHROGENIC ANAEMIA 120 0.0259
48 POST-TRAUMATIC STRESS DISORDER 169 0.0252
49 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 64 0.0240
50 RHINALGIA 66 0.0240
51 NIGHTMARE 823 0.0238
52 POTENTIATING DRUG INTERACTION 76 0.0226
53 GASTROINTESTINAL HYPOMOTILITY 49 0.0217
54 FIBROMYALGIA 508 0.0209
55 PRODUCT ADMINISTRATION INTERRUPTED 161 0.0205
56 DEPRESSIVE SYMPTOM 72 0.0204
57 MATERNAL EXPOSURE DURING BREAST FEEDING 81 0.0199
58 SPINAL STENOSIS 82 0.0198
59 IMPAIRED GASTRIC EMPTYING 269 0.0197
60 RESPIRATORY DEPRESSION 233 0.0190
61 MYOCLONUS 223 0.0187
62 MONOCYTE COUNT INCREASED 67 0.0184
63 FEELING OF DESPAIR 86 0.0184
64 VITAMIN B12 DEFICIENCY 74 0.0183
65 DEMYELINATION 74 0.0180
66 PNEUMONIA ASPIRATION 451 0.0180
67 HYPOMANIA 66 0.0179
68 MAJOR DEPRESSION 131 0.0179
69 BLOOD PRESSURE SYSTOLIC DECREASED 79 0.0174
70 WITHDRAWAL SYNDROME 718 0.0171
71 CERVICAL VERTEBRAL FRACTURE 58 0.0168
72 AUTONOMIC NERVOUS SYSTEM IMBALANCE 49 0.0168
73 ARTERIOSCLEROSIS CORONARY ARTERY 111 0.0167
74 HALLUCINATIONS, MIXED 69 0.0164
75 RED CELL DISTRIBUTION WIDTH INCREASED 68 0.0164
76 BLOOD URIC ACID INCREASED 94 0.0163
77 THROAT CLEARING 61 0.0163
78 VITAMIN D DEFICIENCY 158 0.0162
79 MIOSIS 129 0.0161
80 BRADYPHRENIA 104 0.0159
81 EXPOSURE VIA BREAST MILK 63 0.0158
82 NEUTROPHIL COUNT INCREASED 162 0.0158
83 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 139 0.0157
84 NEPHROLITHIASIS 704 0.0153
85 GRANULOMA 53 0.0153
86 LOSS OF CONTROL OF LEGS 58 0.0153
87 HALLUCINATION, VISUAL 323 0.0153
88 DEPRESSION SUICIDAL 52 0.0150
89 BRUXISM 81 0.0150
90 SNORING 56 0.0148
91 POISONING 186 0.0148
92 ANKYLOSING SPONDYLITIS 194 0.0147
93 TRIGEMINAL NEURALGIA 59 0.0147
94 FOOD POISONING 78 0.0145
95 SELF-INJURIOUS IDEATION 61 0.0145
96 TOXICITY TO VARIOUS AGENTS 2444 0.0145
97 HYPERHIDROSIS 1847 0.0143
98 NEUROLEPTIC MALIGNANT SYNDROME 170 0.0143
99 DRUG INTERACTION 2263 0.0143
100 SUICIDAL IDEATION 1305 0.0142
101 NEURALGIA 344 0.0141
102 PRE-ECLAMPSIA 67 0.0141
103 RESTLESS LEGS SYNDROME 256 0.0141
104 BRAIN FOG 220 0.0140
105 CONCUSSION 107 0.0138
106 INITIAL INSOMNIA 141 0.0137
107 POISONING DELIBERATE 130 0.0137
108 POLYDIPSIA 54 0.0136
109 DELIRIUM 473 0.0136
110 INTENTIONAL SELF-INJURY 275 0.0136
111 BREATH SOUNDS ABNORMAL 67 0.0136
112 INTERVERTEBRAL DISC DEGENERATION 125 0.0135
113 SENSITIVITY TO WEATHER CHANGE 71 0.0135
114 SPINAL DISORDER 126 0.0133
115 COMA 629 0.0132
116 SWOLLEN TONGUE 409 0.0131
117 SPINAL OSTEOARTHRITIS 115 0.0131
118 HALLUCINATION, AUDITORY 207 0.0130
119 IMPAIRED QUALITY OF LIFE 187 0.0130
120 SPONDYLITIS 47 0.0129
121 DISSOCIATION 99 0.0129
122 BLOOD PHOSPHORUS DECREASED 47 0.0128
123 TOXIC ENCEPHALOPATHY 65 0.0128
124 INTENTIONAL OVERDOSE 823 0.0128
125 SLEEP APNOEA SYNDROME 240 0.0126
126 TEARFULNESS 54 0.0125
127 TRIGGER FINGER 51 0.0125
128 PARKINSONISM 121 0.0124
129 MYDRIASIS 159 0.0124
130 CHRONIC KIDNEY DISEASE 932 0.0123
131 LUMBAR VERTEBRAL FRACTURE 56 0.0122
132 SINUS TACHYCARDIA 172 0.0121
133 TENSION HEADACHE 52 0.0121
134 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 577 0.0120
135 CHOLECYSTITIS ACUTE 68 0.0120
136 COORDINATION ABNORMAL 167 0.0120
137 DEPRESSED MOOD 631 0.0119
138 HYPERAESTHESIA 97 0.0118
139 ORTHOSTATIC HYPOTENSION 203 0.0116
140 ANAL INCONTINENCE 104 0.0116
141 BRADYKINESIA 68 0.0115
142 PSORIATIC ARTHROPATHY 460 0.0113
143 BLOOD PRESSURE FLUCTUATION 271 0.0113
144 HYPERAMMONAEMIA 56 0.0112
145 SOPOR 148 0.0112
146 SUICIDE ATTEMPT 677 0.0112
147 DEPRESSED LEVEL OF CONSCIOUSNESS 441 0.0111
148 PARANOIA 192 0.0111
149 LYMPHOEDEMA 77 0.0111
150 TEMPERATURE INTOLERANCE 114 0.0110
151 OSTEOARTHRITIS 465 0.0110
152 NYSTAGMUS 58 0.0109
153 APATHY 159 0.0109
154 DECREASED INTEREST 64 0.0108
155 SEXUAL DYSFUNCTION 127 0.0108
156 AFFECT LABILITY 104 0.0108
157 SKIN ABRASION 51 0.0108
158 HUMERUS FRACTURE 52 0.0108
159 ROTATOR CUFF SYNDROME 138 0.0107
160 HYPERTHERMIA 82 0.0107
161 HYPONATRAEMIA 605 0.0107
162 BEHAVIOUR DISORDER 58 0.0107
163 SPINAL OPERATION 132 0.0107
164 ANKLE FRACTURE 165 0.0106
165 VENTRICULAR SEPTAL DEFECT 61 0.0106
166 TRISMUS 55 0.0106
167 URINARY RETENTION 353 0.0106
168 MUSCLE RIGIDITY 126 0.0105
169 SEASONAL ALLERGY 149 0.0105
170 SARS-COV-2 TEST POSITIVE 139 0.0105
171 NEUROPATHY PERIPHERAL 1000 0.0105
172 DISTURBANCE IN ATTENTION 567 0.0105
173 FEELING DRUNK 78 0.0105
174 SPINAL PAIN 122 0.0104
175 APNOEA 81 0.0104
176 MANIA 171 0.0104
177 HALLUCINATION 783 0.0104
178 INTERVERTEBRAL DISC PROTRUSION 226 0.0103
179 SOMNOLENCE 2076 0.0103
180 JOINT EFFUSION 71 0.0103
181 DYSPHORIA 52 0.0103
182 ON AND OFF PHENOMENON 57 0.0103
183 ENCEPHALOPATHY 252 0.0103
184 COGNITIVE DISORDER 479 0.0102
185 THINKING ABNORMAL 191 0.0102
186 MENISCUS INJURY 63 0.0102
187 BURSITIS 124 0.0102
188 LIGAMENT SPRAIN 101 0.0102
189 INFUSION SITE ERYTHEMA 86 0.0102
190 GASTROOESOPHAGEAL REFLUX DISEASE 821 0.0102
191 BALANCE DISORDER 873 0.0101
192 DEPRESSION 2296 0.0101
193 NERVE COMPRESSION 93 0.0101
194 DELUSION 155 0.0100
195 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 82 0.0099
196 RESPIRATORY ARREST 274 0.0099
197 PAROSMIA 75 0.0099
198 HYPOKINESIA 144 0.0099
199 DIZZINESS POSTURAL 96 0.0099
200 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 543 0.0099
201 BLOOD IRON DECREASED 117 0.0099
202 PERONEAL NERVE PALSY 56 0.0098
203 INFUSION SITE SWELLING 62 0.0098
204 HYPERVENTILATION 57 0.0098
205 RIB FRACTURE 202 0.0098
206 DYSKINESIA 398 0.0098
207 END STAGE RENAL DISEASE 178 0.0097
208 PSYCHOTIC DISORDER 288 0.0097
209 DISORIENTATION 385 0.0097
210 MUSCLE STRAIN 84 0.0097
211 DIABETIC NEUROPATHY 48 0.0097
212 BODY TEMPERATURE DECREASED 95 0.0096
213 NEUROLOGICAL SYMPTOM 55 0.0096
214 ELECTROCARDIOGRAM QT PROLONGED 346 0.0096
215 RESPIRATION ABNORMAL 66 0.0096
216 POOR QUALITY SLEEP 206 0.0096
217 WALKING AID USER 63 0.0095
218 DRUG LEVEL INCREASED 158 0.0095
219 ANGER 321 0.0095
220 PRE-EXISTING CONDITION IMPROVED 59 0.0094
221 ATELECTASIS 91 0.0094
222 SCHIZOPHRENIA 114 0.0094
223 BLADDER DISORDER 93 0.0094
224 DYSTONIA 181 0.0093
225 CONFUSIONAL STATE 1504 0.0093
226 APHTHOUS ULCER 72 0.0093
227 PATHOLOGICAL FRACTURE 47 0.0093
228 HYPERNATRAEMIA 46 0.0092
229 LEUKOCYTOSIS 167 0.0092
230 SCIATICA 147 0.0092
231 INSURANCE ISSUE 141 0.0092
232 CRYING 334 0.0092
233 PRODUCT SUBSTITUTION ISSUE 529 0.0092
234 URINE ODOUR ABNORMAL 54 0.0092
235 URINARY INCONTINENCE 272 0.0092
236 FALL 3055 0.0092
237 DYSPHONIA 534 0.0091
238 HYSTERECTOMY 79 0.0091
239 TREMOR 1508 0.0091
240 HYPERSOMNIA 260 0.0091
241 SLEEP DISORDER 640 0.0091
242 LYMPHOCYTE COUNT DECREASED 159 0.0090
243 NOCTURIA 109 0.0090
244 ATRIAL SEPTAL DEFECT 75 0.0089
245 IRRITABLE BOWEL SYNDROME 192 0.0089
246 CARDIO-RESPIRATORY ARREST 374 0.0089
247 FAECALOMA 49 0.0089
248 BLOOD PRESSURE DIASTOLIC DECREASED 66 0.0089
249 CARPAL TUNNEL SYNDROME 125 0.0089
250 OXYGEN SATURATION DECREASED 501 0.0089
251 QUALITY OF LIFE DECREASED 119 0.0089
252 PSYCHOMOTOR HYPERACTIVITY 147 0.0088
253 SENSORY DISTURBANCE 142 0.0088
254 MEMORY IMPAIRMENT 1215 0.0088
255 ACUTE KIDNEY INJURY 1350 0.0088
256 ADRENAL INSUFFICIENCY 107 0.0088
257 SOCIAL AVOIDANT BEHAVIOUR 51 0.0088
258 DECREASED ACTIVITY 95 0.0088
259 RHINITIS 71 0.0088
260 GLUCOSE TOLERANCE IMPAIRED 52 0.0088
261 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 149 0.0088
262 ASPIRATION 96 0.0088
263 OBESITY 139 0.0087
264 PRODUCT DOSE OMISSION IN ERROR 247 0.0087
265 PHOTOPHOBIA 164 0.0087
266 MIGRAINE 829 0.0087
267 TROPONIN INCREASED 66 0.0087
268 MOUTH SWELLING 50 0.0087
269 COVID-19 PNEUMONIA 102 0.0086
270 PRODUCT DISTRIBUTION ISSUE 80 0.0086
271 NEUTROPHILIA 49 0.0086
272 UNRESPONSIVE TO STIMULI 222 0.0086
273 STRESS CARDIOMYOPATHY 50 0.0086
274 BLOOD POTASSIUM DECREASED 258 0.0086
275 IRON DEFICIENCY ANAEMIA 79 0.0085
276 HYPERTONIA 49 0.0085
277 OBSTRUCTIVE AIRWAYS DISORDER 95 0.0085
278 INFUSION SITE PAIN 110 0.0085
279 SOMNAMBULISM 56 0.0085
280 HEAD INJURY 270 0.0085
281 INCONTINENCE 90 0.0085
282 LIMB INJURY 231 0.0085
283 RED BLOOD CELL SEDIMENTATION RATE INCREASED 94 0.0085
284 MICTURITION URGENCY 97 0.0085
285 BACK DISORDER 138 0.0085
286 MUSCULOSKELETAL DISCOMFORT 146 0.0085
287 BRAIN INJURY 85 0.0085
288 GASTROINTESTINAL PAIN 93 0.0084
289 MENTAL DISORDER 367 0.0084
290 AKATHISIA 115 0.0084
291 ANHEDONIA 221 0.0084
292 DRY MOUTH 680 0.0084
293 CARDIOMEGALY 103 0.0084
294 MUSCLE SPASTICITY 102 0.0083
295 CYST 103 0.0083
296 FRUSTRATION TOLERANCE DECREASED 67 0.0083
297 MULTIPLE ALLERGIES 65 0.0083
298 PULMONARY CONGESTION 109 0.0083
299 VERTIGO 503 0.0082
300 RESTLESSNESS 302 0.0082
301 UROSEPSIS 76 0.0082
302 FOOT FRACTURE 156 0.0082
303 MENTAL STATUS CHANGES 228 0.0082
304 GAIT INABILITY 274 0.0082
305 DRUG INTOLERANCE 791 0.0082
306 FACIAL PAIN 73 0.0082
307 EXTRAPYRAMIDAL DISORDER 203 0.0082
308 INTENTIONAL DOSE OMISSION 233 0.0082
309 DEMENTIA 228 0.0082
310 DRUG ABUSE 679 0.0081
311 GAIT DISTURBANCE 1556 0.0081
312 DYSSTASIA 237 0.0081
313 MULTIPLE SCLEROSIS 388 0.0081
314 HYPOTHERMIA 82 0.0081
315 NECK PAIN 450 0.0080
316 MENTAL IMPAIRMENT 195 0.0080
317 HYPOVOLAEMIA 47 0.0080
318 FOOT DEFORMITY 89 0.0080
319 SCREAMING 51 0.0080
320 BIPOLAR DISORDER 87 0.0080
321 ILLNESS 824 0.0080
322 EXOSTOSIS 73 0.0080
323 MOVEMENT DISORDER 256 0.0080
324 TINNITUS 366 0.0080
325 SWELLING FACE 518 0.0079
326 SUBARACHNOID HAEMORRHAGE 81 0.0079
327 SENSORY LOSS 64 0.0079
328 AGITATION 581 0.0079
329 SCOLIOSIS 49 0.0079
330 SKIN LACERATION 86 0.0079
331 OSTEOPENIA 120 0.0079
332 HAND FRACTURE 56 0.0079
333 PANIC REACTION 57 0.0079
334 GRIP STRENGTH DECREASED 69 0.0078
335 NERVE INJURY 87 0.0078
336 HYPERTENSIVE CRISIS 87 0.0078
337 ALTERED STATE OF CONSCIOUSNESS 169 0.0078
338 CONSTIPATION 1691 0.0077
339 POST PROCEDURAL INFECTION 63 0.0077
340 GROIN PAIN 68 0.0077
341 BLOOD PRESSURE SYSTOLIC INCREASED 151 0.0077
342 SUBSTANCE ABUSE 63 0.0077
343 HEPATIC STEATOSIS 144 0.0077
344 HIATUS HERNIA 100 0.0077
345 URINARY TRACT INFECTION 1315 0.0077
346 RENAL INJURY 229 0.0077
347 LOSS OF LIBIDO 69 0.0077
348 IMMUNODEFICIENCY 114 0.0076
349 ORAL PAIN 171 0.0076
350 BLOOD TEST ABNORMAL 107 0.0076
351 VITAMIN D DECREASED 65 0.0076
352 EAR DISCOMFORT 78 0.0076
353 MUSCLE TWITCHING 175 0.0076
354 THERAPEUTIC RESPONSE CHANGED 48 0.0076
355 TENSION 46 0.0075
356 MIDDLE INSOMNIA 141 0.0075
357 IRRITABILITY 453 0.0075
358 ANXIETY 2128 0.0075
359 PRODUCT PRESCRIBING ERROR 178 0.0075
360 ANGIOEDEMA 330 0.0075
361 POLYURIA 61 0.0074
362 GASTROENTERITIS VIRAL 134 0.0074
363 ATAXIA 88 0.0074
364 SCRATCH 78 0.0074
365 INFUSION SITE EXTRAVASATION 46 0.0074
366 CYSTITIS 235 0.0074
367 ULCER 117 0.0073
368 MUSCULOSKELETAL STIFFNESS 643 0.0073
369 PSYCHIATRIC SYMPTOM 54 0.0073
370 HYPERLIPIDAEMIA 87 0.0073
371 EYE PAIN 410 0.0073
372 NIGHT SWEATS 233 0.0072
373 MUSCLE TIGHTNESS 117 0.0072
374 OCULAR DISCOMFORT 81 0.0072
375 TACHYCARDIA 641 0.0072
376 AMNESIA 469 0.0072
377 LIMB DISCOMFORT 223 0.0072
378 BACK PAIN 1673 0.0072
379 TASTE DISORDER 146 0.0072
380 PELVIC FRACTURE 56 0.0072
381 THERAPY INTERRUPTED 513 0.0072
382 MUSCULAR WEAKNESS 815 0.0072
383 COVID-19 1250 0.0071
384 HEAD DISCOMFORT 126 0.0071
385 LOSS OF CONSCIOUSNESS 908 0.0071
386 UPPER RESPIRATORY TRACT INFECTION 327 0.0071
387 PARAESTHESIA 1113 0.0071
388 LOCALISED INFECTION 171 0.0071
389 SLUGGISHNESS 72 0.0071
390 TENDON DISORDER 46 0.0070
391 KIDNEY INFECTION 138 0.0070
392 APHASIA 212 0.0070
393 ARTHROPOD BITE 52 0.0070
394 SKIN HAEMORRHAGE 104 0.0070
395 DEFAECATION URGENCY 49 0.0070
396 HEPATIC CYTOLYSIS 89 0.0070
397 CELLULITIS 351 0.0070
398 ORAL DISORDER 51 0.0070
399 DERMATITIS CONTACT 79 0.0069
400 FACIAL PARALYSIS 59 0.0069
401 GASTROINTESTINAL INFECTION 62 0.0069
402 ACUTE RESPIRATORY FAILURE 133 0.0069
403 ARTHRITIS 543 0.0069
404 CEREBRAL DISORDER 51 0.0069
405 SUPRAVENTRICULAR TACHYCARDIA 66 0.0069
406 INSOMNIA 1836 0.0069
407 HYPOTHYROIDISM 220 0.0069
408 KNEE ARTHROPLASTY 145 0.0069
409 HYPOPHAGIA 176 0.0069
410 EYE MOVEMENT DISORDER 47 0.0069
411 SINUSITIS 698 0.0068
412 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 484 0.0068
413 DRUG WITHDRAWAL SYNDROME 595 0.0068
414 SENSATION OF FOREIGN BODY 57 0.0068
415 NAUSEA 5344 0.0067
416 TOOTH INFECTION 89 0.0067
417 ABNORMAL LOSS OF WEIGHT 46 0.0067
418 PHARYNGEAL SWELLING 66 0.0067
419 MULTIPLE SCLEROSIS RELAPSE 462 0.0067
420 FATIGUE 5240 0.0067
421 RETCHING 143 0.0067
422 IMMUNOSUPPRESSION 59 0.0067
423 HOSPICE CARE 66 0.0067
424 PRODUCT ADMINISTRATION ERROR 135 0.0067
425 DIZZINESS 3330 0.0067
426 THERAPY NON-RESPONDER 300 0.0067
427 WRIST FRACTURE 80 0.0067
428 THIRST 119 0.0067
429 CONTUSION 641 0.0067
430 C-REACTIVE PROTEIN INCREASED 242 0.0066
431 MOOD SWINGS 212 0.0066
432 BLOOD UREA INCREASED 111 0.0066
433 ABNORMAL DREAMS 183 0.0066
434 MOBILITY DECREASED 476 0.0066
435 DYSARTHRIA 249 0.0066
436 HYPOTONIA 66 0.0066
437 DRUG TOXICITY 90 0.0066
438 BLOOD MAGNESIUM DECREASED 57 0.0066
439 THERAPY PARTIAL RESPONDER 103 0.0066
440 APHONIA 92 0.0066
441 HYPOAESTHESIA 986 0.0066
442 NASAL CONGESTION 387 0.0066
443 BRONCHITIS 487 0.0066
444 PAIN 4037 0.0066
445 PANIC ATTACK 239 0.0066
446 RESPIRATORY SYNCYTIAL VIRUS INFECTION 57 0.0065
447 GENERALISED TONIC-CLONIC SEIZURE 108 0.0065
448 PULMONARY MASS 97 0.0065
449 DIPLOPIA 169 0.0065
450 ORAL HERPES 127 0.0065
451 HYPOXIA 229 0.0065
452 WEIGHT FLUCTUATION 68 0.0065
453 SUBDURAL HAEMATOMA 93 0.0065
454 THROAT IRRITATION 291 0.0065
455 HEADACHE 4048 0.0064
456 LOWER LIMB FRACTURE 124 0.0064
457 TYPE 2 DIABETES MELLITUS 217 0.0064
458 INTENTIONAL PRODUCT MISUSE 564 0.0064
459 UPPER-AIRWAY COUGH SYNDROME 53 0.0064
460 SMALL INTESTINAL OBSTRUCTION 79 0.0064
461 JOINT STIFFNESS 168 0.0064
462 PERIPHERAL SWELLING 986 0.0064
463 HIP ARTHROPLASTY 98 0.0064
464 LOWER RESPIRATORY TRACT INFECTION 291 0.0064
465 SYNOVITIS 115 0.0064
466 DRUG-INDUCED LIVER INJURY 200 0.0064
467 BLOOD URINE PRESENT 121 0.0064
468 ELECTROLYTE IMBALANCE 74 0.0064
469 UPPER GASTROINTESTINAL HAEMORRHAGE 107 0.0064
470 FOOD ALLERGY 49 0.0063
471 IMPAIRED DRIVING ABILITY 72 0.0063
472 FAECES SOFT 46 0.0063
473 JOINT INJURY 135 0.0063
474 DYSPNOEA EXERTIONAL 238 0.0063
475 BEDRIDDEN 83 0.0063
476 HAEMODYNAMIC INSTABILITY 48 0.0063
477 BODY HEIGHT DECREASED 67 0.0063
478 SINUS DISORDER 124 0.0063
479 METABOLIC ACIDOSIS 200 0.0062
480 TACHYPNOEA 85 0.0062
481 DYSURIA 230 0.0062
482 ASPHYXIA 51 0.0062
483 PAIN IN EXTREMITY 1840 0.0062
484 OROPHARYNGEAL PAIN 578 0.0062
485 TUBULOINTERSTITIAL NEPHRITIS 117 0.0062
486 TOOTHACHE 113 0.0062
487 OROPHARYNGEAL DISCOMFORT 56 0.0062
488 HYPOTENSION 1243 0.0062
489 INCREASED TENDENCY TO BRUISE 57 0.0062
490 THERAPY CESSATION 318 0.0062
491 DRUG USE DISORDER 52 0.0062
492 BLOOD PRESSURE INCREASED 945 0.0062
493 WHITE BLOOD CELL COUNT INCREASED 237 0.0062
494 ARTHRALGIA 2568 0.0062
495 PRODUCT USE IN UNAPPROVED INDICATION 1525 0.0061
496 EUPHORIC MOOD 63 0.0061
497 IMMUNE SYSTEM DISORDER 81 0.0061
498 SEIZURE 708 0.0061
499 CHOLECYSTECTOMY 70 0.0061
500 WEIGHT INCREASED 1372 0.0061
501 WOUND INFECTION 67 0.0061
502 DECREASED APPETITE 1421 0.0061
503 PRODUCT DOSE OMISSION ISSUE 1799 0.0061
504 RESPIRATORY DISORDER 183 0.0061
505 FEELING ABNORMAL 1461 0.0061
506 CONDITION AGGRAVATED 1849 0.0061
507 DYSPEPSIA 598 0.0061
508 DRUG EFFECT LESS THAN EXPECTED 90 0.0061
509 MUCOSAL INFLAMMATION 159 0.0061
510 INFLUENZA 677 0.0061
511 TARDIVE DYSKINESIA 171 0.0061
512 PRODUCTIVE COUGH 289 0.0060
513 ASTHMA 684 0.0060
514 MACULAR DEGENERATION 72 0.0060
515 OSTEOPOROSIS 248 0.0060
516 WHEEZING 357 0.0060
517 SYNCOPE 602 0.0060
518 RENAL TUBULAR NECROSIS 59 0.0060
519 DRY EYE 300 0.0060
520 MUSCULOSKELETAL CHEST PAIN 93 0.0060
521 HYPERCHOLESTEROLAEMIA 58 0.0060
522 HEPATIC ENCEPHALOPATHY 56 0.0060
523 KNEE OPERATION 59 0.0060
524 TENDON RUPTURE 74 0.0060
525 POOR VENOUS ACCESS 62 0.0060
526 POST PROCEDURAL COMPLICATION 115 0.0060
527 AGGRESSION 299 0.0060
528 RHINORRHOEA 386 0.0060
529 PERIPHERAL COLDNESS 82 0.0060
530 HOT FLUSH 450 0.0060
531 SURGERY 350 0.0060
532 HERPES ZOSTER 343 0.0060
533 EAR PAIN 116 0.0060
534 HYPOKALAEMIA 275 0.0060
535 RHABDOMYOLYSIS 248 0.0059
536 RHEUMATOID ARTHRITIS 675 0.0059
537 CONTRAINDICATED PRODUCT ADMINISTERED 180 0.0059
538 BLOOD SODIUM DECREASED 112 0.0059
539 TENDONITIS 92 0.0059
540 ARTHROPATHY 330 0.0059
541 SPEECH DISORDER 311 0.0059
542 HYPERTENSION 1255 0.0059
543 GINGIVAL PAIN 47 0.0059
544 THERAPY CHANGE 58 0.0059
545 LETHARGY 339 0.0059
546 JOINT RANGE OF MOTION DECREASED 79 0.0059
547 DIVERTICULITIS 163 0.0059
548 BLOOD ALKALINE PHOSPHATASE INCREASED 146 0.0059
549 MOOD ALTERED 160 0.0059
550 CLOSTRIDIUM DIFFICILE COLITIS 62 0.0058
551 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 304 0.0058
552 FEELING JITTERY 111 0.0058
553 PERSONALITY CHANGE 54 0.0058
554 TOOTH FRACTURE 64 0.0058
555 FURUNCLE 46 0.0058
556 CANDIDA INFECTION 98 0.0058
557 FOETAL EXPOSURE DURING PREGNANCY 471 0.0058
558 MOTOR DYSFUNCTION 59 0.0058
559 SPINAL FRACTURE 116 0.0058
560 LIVER FUNCTION TEST INCREASED 124 0.0058
561 VOMITING 2710 0.0058
562 EYE INFECTION 65 0.0058
563 PAIN IN JAW 163 0.0057
564 CARDIAC ARREST 474 0.0057
565 ARTERIOSCLEROSIS 54 0.0057
566 MUSCLE SPASMS 1051 0.0057
567 BLOOD CREATINE PHOSPHOKINASE INCREASED 164 0.0057
568 DENTAL CARIES 63 0.0057
569 SPUTUM DISCOLOURED 54 0.0057
570 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 97 0.0057
571 FRACTURE 107 0.0056
572 THYROID DISORDER 87 0.0056
573 INTENTIONAL PRODUCT USE ISSUE 494 0.0056
574 THERAPEUTIC RESPONSE SHORTENED 187 0.0056
575 ALANINE AMINOTRANSFERASE INCREASED 346 0.0056
576 MEDICATION ERROR 313 0.0056
577 ASTHENIA 2117 0.0056
578 ABNORMAL BEHAVIOUR 223 0.0056
579 COLD SWEAT 99 0.0056
580 ABDOMINAL PAIN UPPER 1156 0.0056
581 SKIN ULCER 145 0.0056
582 RESPIRATORY TRACT INFECTION 146 0.0056
583 HAEMATEMESIS 142 0.0056
584 INCREASED APPETITE 107 0.0056
585 DIARRHOEA 3613 0.0056
586 BLOOD PRESSURE ABNORMAL 111 0.0056
587 RENAL FAILURE 740 0.0056
588 MYOPATHY 48 0.0056
589 SCAR 95 0.0055
590 WEIGHT DECREASED 1548 0.0055
591 BRAIN OEDEMA 70 0.0055
592 NEUROTOXICITY 97 0.0055
593 COUGH 1552 0.0055
594 CIRCULATORY COLLAPSE 94 0.0055
595 BACK INJURY 60 0.0055
596 HYPERCALCAEMIA 68 0.0055
597 FEELING HOT 337 0.0055
598 VENTRICULAR FIBRILLATION 61 0.0055
599 RED BLOOD CELL COUNT DECREASED 157 0.0055
600 FULL BLOOD COUNT ABNORMAL 58 0.0055
601 ABDOMINAL PAIN 1275 0.0055
602 NERVOUSNESS 286 0.0055
603 MUSCULOSKELETAL DISORDER 104 0.0055
604 PSYCHOLOGICAL TRAUMA 47 0.0054
605 LYMPHOPENIA 77 0.0054
606 MUSCULOSKELETAL PAIN 285 0.0054
607 SKIN INFECTION 61 0.0054
608 ACUTE CORONARY SYNDROME 45 0.0054
609 DYSPHAGIA 512 0.0054
610 ORAL CANDIDIASIS 71 0.0054
611 HERNIA 104 0.0054
612 EAR INFECTION 143 0.0054
613 HYPOAESTHESIA ORAL 81 0.0054
614 PNEUMONIA 1735 0.0054
615 PALPITATIONS 626 0.0053
616 INABILITY TO AFFORD MEDICATION 53 0.0053
617 ABDOMINAL DISCOMFORT 893 0.0053
618 ACUTE RESPIRATORY DISTRESS SYNDROME 94 0.0053
619 TOOTH ABSCESS 54 0.0053
620 VITREOUS FLOATERS 52 0.0053
621 HAEMORRHOIDS 103 0.0053
622 FEEDING DISORDER 107 0.0053
623 EATING DISORDER 112 0.0053
624 HEART RATE INCREASED 521 0.0053
625 INFLAMMATION 271 0.0052
626 HAEMATOMA 136 0.0052
627 VISION BLURRED 717 0.0052
628 UPPER LIMB FRACTURE 104 0.0052
629 OFF LABEL USE 4568 0.0052
630 FEELING COLD 145 0.0052
631 SQUAMOUS CELL CARCINOMA 49 0.0052
632 DISCOMFORT 317 0.0052
633 DERMATITIS ALLERGIC 65 0.0052
634 FLATULENCE 293 0.0052
635 NASOPHARYNGITIS 949 0.0051
636 TOOTH EXTRACTION 64 0.0051
637 OSTEOMYELITIS 93 0.0051
638 GASTRITIS 135 0.0051
639 DEHYDRATION 683 0.0051
640 HYPERKALAEMIA 179 0.0051
641 RESPIRATORY TRACT CONGESTION 81 0.0051
642 ANGINA PECTORIS 146 0.0051
643 LIVER FUNCTION TEST ABNORMAL 148 0.0051
644 MASS 71 0.0051
645 GLYCOSYLATED HAEMOGLOBIN INCREASED 128 0.0051
646 HIP FRACTURE 163 0.0051
647 ABDOMINAL DISTENSION 528 0.0051
648 EMPHYSEMA 51 0.0051
649 LIVER INJURY 124 0.0050
650 PARALYSIS 72 0.0050
651 CARDIOGENIC SHOCK 72 0.0050
652 HEMIPARESIS 85 0.0050
653 IMPAIRED WORK ABILITY 107 0.0050
654 RENAL PAIN 53 0.0050
655 PRODUCT DOSE OMISSION 326 0.0050
656 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 900 0.0050
657 DECREASED IMMUNE RESPONSIVENESS 49 0.0050
658 BURNING SENSATION 350 0.0050
659 HEART RATE DECREASED 175 0.0050
660 WOUND 139 0.0050
661 PHOTOSENSITIVITY REACTION 82 0.0050
662 HEART RATE IRREGULAR 112 0.0050
663 CENTRAL NERVOUS SYSTEM LESION 68 0.0049
664 FEAR 133 0.0049
665 PRESYNCOPE 120 0.0049
666 BLOOD GLUCOSE FLUCTUATION 54 0.0049
667 MYALGIA 837 0.0049
668 SKIN LESION 135 0.0049
669 HYPERSENSITIVITY 913 0.0049
670 MALNUTRITION 55 0.0049
671 POLLAKIURIA 204 0.0049
672 PALLOR 133 0.0049
673 CATARACT 291 0.0049
674 EOSINOPHILIA 85 0.0048
675 OVERDOSE 1043 0.0048
676 EMOTIONAL DISORDER 149 0.0048
677 DIABETIC KETOACIDOSIS 116 0.0048
678 INTESTINAL OBSTRUCTION 182 0.0048
679 PULMONARY OEDEMA 216 0.0048
680 GASTROINTESTINAL DISORDER 431 0.0048
681 NEPHROPATHY TOXIC 54 0.0048
682 PHARYNGITIS STREPTOCOCCAL 52 0.0048
683 CHEST DISCOMFORT 491 0.0048
684 STAPHYLOCOCCAL INFECTION 158 0.0048
685 ROAD TRAFFIC ACCIDENT 200 0.0048
686 HEPATIC FUNCTION ABNORMAL 178 0.0048
687 BRADYCARDIA 252 0.0047
688 PRODUCT AVAILABILITY ISSUE 108 0.0047
689 SINUS CONGESTION 64 0.0047
690 SKIN DISORDER 158 0.0047
691 JOINT DISLOCATION 50 0.0047
692 DRY THROAT 48 0.0047
693 GLOMERULAR FILTRATION RATE DECREASED 58 0.0047
694 ABORTION SPONTANEOUS 189 0.0047
695 SKIN FISSURES 92 0.0047
696 INFLUENZA LIKE ILLNESS 387 0.0047
697 SALIVARY HYPERSECRETION 47 0.0047
698 BLOOD POTASSIUM INCREASED 76 0.0047
699 TOOTH DISORDER 104 0.0047
700 VENTRICULAR TACHYCARDIA 77 0.0047
701 INFECTION 673 0.0046
702 VISUAL IMPAIRMENT 576 0.0046
703 PSORIASIS 607 0.0046
704 CYANOSIS 73 0.0046
705 GASTRIC ULCER 88 0.0046
706 CLOSTRIDIUM DIFFICILE INFECTION 101 0.0046
707 SYSTEMIC LUPUS ERYTHEMATOSUS 164 0.0046
708 SEPSIS 515 0.0046
709 BACTERIAL INFECTION 86 0.0046
710 TENDERNESS 48 0.0046
711 ORAL DISCOMFORT 64 0.0046
712 GENERALISED OEDEMA 57 0.0046
713 THERAPEUTIC RESPONSE DECREASED 279 0.0046
714 HEREDITARY ANGIOEDEMA 49 0.0046
715 COLITIS 173 0.0046
716 CHEST PAIN 845 0.0046
717 MOUTH ULCERATION 96 0.0046
718 FREQUENT BOWEL MOVEMENTS 123 0.0045
719 LIP SWELLING 151 0.0045
720 THERAPEUTIC PRODUCT EFFECT DECREASED 203 0.0045
721 BLISTER 254 0.0045
722 BONE PAIN 264 0.0045
723 ILEUS 56 0.0045
724 PROCEDURAL PAIN 125 0.0045
725 PARAESTHESIA ORAL 65 0.0045
726 RASH PRURITIC 244 0.0045
727 BREAST PAIN 48 0.0045
728 DYSPNOEA 2547 0.0045
729 INFUSION RELATED REACTION 298 0.0045
730 JOINT SWELLING 542 0.0045
731 TREATMENT NONCOMPLIANCE 245 0.0045
732 HEPATIC ENZYME INCREASED 305 0.0045
733 FUNGAL INFECTION 149 0.0045
734 BLOOD PRESSURE DECREASED 297 0.0045
735 HYPOACUSIS 192 0.0045
736 ACCIDENTAL OVERDOSE 163 0.0045
737 MALAISE 1953 0.0044
738 EXPOSURE DURING PREGNANCY 276 0.0044
739 RENAL IMPAIRMENT 372 0.0044
740 STATUS EPILEPTICUS 50 0.0044
741 ECONOMIC PROBLEM 67 0.0044
742 FULL BLOOD COUNT DECREASED 89 0.0044
743 BLOOD TRIGLYCERIDES INCREASED 78 0.0044
744 LUNG DISORDER 216 0.0044
745 FLUID RETENTION 224 0.0044
746 PULMONARY THROMBOSIS 48 0.0044
747 ABDOMINAL PAIN LOWER 111 0.0044
748 GASTROENTERITIS 64 0.0044
749 ATRIAL FIBRILLATION 427 0.0044
750 EPILEPSY 134 0.0044
751 VIRAL INFECTION 145 0.0044
752 DIABETES MELLITUS 332 0.0044
753 GENERAL PHYSICAL HEALTH DETERIORATION 503 0.0043
754 MUSCLE ATROPHY 55 0.0043
755 BONE DISORDER 79 0.0043
756 ACUTE HEPATIC FAILURE 59 0.0043
757 HEPATIC CIRRHOSIS 81 0.0043
758 PRURITUS 1652 0.0043
759 CHILLS 503 0.0043
760 NODULE 56 0.0043
761 DRUG INEFFECTIVE 5654 0.0043
762 MYOCARDITIS 49 0.0043
763 TREATMENT FAILURE 353 0.0043
764 POLYNEUROPATHY 51 0.0043
765 CHOLELITHIASIS 139 0.0042
766 RASH MACULAR 148 0.0042
767 ANAPHYLACTIC REACTION 233 0.0042
768 PRESCRIBED UNDERDOSE 84 0.0042
769 OESOPHAGITIS 46 0.0042
770 CHROMATURIA 95 0.0042
771 BLOOD GLUCOSE DECREASED 202 0.0042
772 BLOOD CHOLESTEROL INCREASED 196 0.0042
773 ASPARTATE AMINOTRANSFERASE INCREASED 223 0.0042
774 EYE DISORDER 138 0.0042
775 CHOLECYSTITIS 50 0.0042
776 TOOTH LOSS 87 0.0042
777 STOMATITIS 254 0.0042
778 HAEMATOCRIT DECREASED 83 0.0042
779 HAEMATOCHEZIA 231 0.0042
780 SWELLING 391 0.0042
781 THROAT TIGHTNESS 113 0.0042
782 BODY TEMPERATURE INCREASED 85 0.0042
783 SECRETION DISCHARGE 52 0.0041
784 RESPIRATORY FAILURE 302 0.0041
785 LEUKOPENIA 207 0.0041
786 PRESCRIBED OVERDOSE 80 0.0041
787 ACCIDENT 49 0.0041
788 CHOKING 80 0.0041
789 MATERNAL EXPOSURE DURING PREGNANCY 358 0.0040
790 FAECES DISCOLOURED 87 0.0040
791 AGEUSIA 100 0.0040
792 ACUTE MYOCARDIAL INFARCTION 118 0.0040
793 NERVOUS SYSTEM DISORDER 124 0.0040
794 TRANSIENT ISCHAEMIC ATTACK 134 0.0040
795 GAMMA-GLUTAMYLTRANSFERASE INCREASED 88 0.0040
796 ALOPECIA 779 0.0040
797 PELVIC PAIN 72 0.0040
798 OEDEMA PERIPHERAL 482 0.0040
799 PRODUCT PRESCRIBING ISSUE 86 0.0039
800 PRODUCT USE COMPLAINT 62 0.0039
801 PANCREATITIS ACUTE 88 0.0039
802 CORONARY ARTERY OCCLUSION 53 0.0039
803 ERECTILE DYSFUNCTION 99 0.0039
804 FEMUR FRACTURE 119 0.0038
805 CYTOPENIA 47 0.0038
806 SNEEZING 86 0.0038
807 LIVER DISORDER 170 0.0038
808 RENAL DISORDER 178 0.0038
809 PNEUMONITIS 104 0.0038
810 SKIN DISCOLOURATION 175 0.0038
811 FLUSHING 387 0.0038
812 ECZEMA 199 0.0038
813 BLOOD CREATININE INCREASED 248 0.0038
814 PHARYNGITIS 47 0.0038
815 EYE IRRITATION 217 0.0038
816 DEVICE RELATED INFECTION 58 0.0038
817 DRUG PRESCRIBING ERROR 72 0.0037
818 ADVERSE DRUG REACTION 336 0.0037
819 ANAEMIA 706 0.0037
820 PULMONARY HYPERTENSION 77 0.0037
821 HEPATIC FAILURE 111 0.0037
822 SKIN EXFOLIATION 310 0.0037
823 RASH PAPULAR 82 0.0037
824 GOUT 65 0.0036
825 HAIR COLOUR CHANGES 45 0.0036
826 URTICARIA 605 0.0036
827 UNEVALUABLE EVENT 273 0.0036
828 HEPATITIS 92 0.0036
829 PANCREATITIS 190 0.0036
830 LYMPHADENOPATHY 127 0.0036
831 HYPOGLYCAEMIA 174 0.0036
832 LACTIC ACIDOSIS 116 0.0036
833 OEDEMA 194 0.0036
834 BRONCHOSPASM 51 0.0036
835 BLOOD COUNT ABNORMAL 54 0.0036
836 PRODUCT USE ISSUE 665 0.0035
837 PLATELET COUNT INCREASED 46 0.0035
838 GASTRIC DISORDER 121 0.0035
839 GINGIVAL BLEEDING 48 0.0035
840 HYPERGLYCAEMIA 128 0.0035
841 DISEASE RECURRENCE 167 0.0035
842 ABSCESS 56 0.0035
843 HAEMOGLOBIN DECREASED 360 0.0035
844 PERICARDIAL EFFUSION 81 0.0035
845 RASH 1523 0.0035
846 CEREBRAL HAEMORRHAGE 125 0.0035
847 DERMATITIS ATOPIC 184 0.0035
848 PULMONARY EMBOLISM 330 0.0035
849 EYE SWELLING 129 0.0035
850 HYPOMAGNESAEMIA 48 0.0034
851 EYE HAEMORRHAGE 46 0.0034
852 CHOLESTASIS 66 0.0034
853 BLINDNESS 140 0.0034
854 THROMBOSIS 276 0.0034
855 EPISTAXIS 256 0.0034
856 GALLBLADDER DISORDER 61 0.0034
857 NEEDLE ISSUE 99 0.0034
858 CONJUNCTIVITIS 63 0.0034
859 PRODUCT PHYSICAL ISSUE 68 0.0034
860 MELAENA 74 0.0034
861 PLATELET COUNT DECREASED 356 0.0033
862 SEPTIC SHOCK 145 0.0033
863 DRUG ERUPTION 59 0.0033
864 GLAUCOMA 64 0.0033
865 IMPAIRED HEALING 109 0.0033
866 MULTIPLE ORGAN DYSFUNCTION SYNDROME 94 0.0033
867 PYREXIA 1145 0.0033
868 WHITE BLOOD CELL COUNT DECREASED 358 0.0033
869 HAEMATURIA 113 0.0033
870 TRANSAMINASES INCREASED 73 0.0033
871 INTERSTITIAL LUNG DISEASE 158 0.0033
872 THERAPEUTIC RESPONSE UNEXPECTED 145 0.0032
873 PLASMA CELL MYELOMA 126 0.0032
874 HAEMOPTYSIS 90 0.0032
875 CARDIAC DISORDER 301 0.0032
876 DEVICE OCCLUSION 45 0.0032
877 DRY SKIN 426 0.0032
878 BLINDNESS UNILATERAL 45 0.0032
879 CARDIAC FAILURE 255 0.0032
880 ARRHYTHMIA 150 0.0032
881 INJECTION SITE BRUISING 252 0.0032
882 PAIN OF SKIN 85 0.0032
883 EYE PRURITUS 106 0.0032
884 UNDERDOSE 229 0.0031
885 METASTASES TO LIVER 55 0.0031
886 EXPOSURE VIA SKIN CONTACT 81 0.0031
887 INJECTION SITE WARMTH 64 0.0031
888 PLEURAL EFFUSION 189 0.0031
889 DERMATITIS 65 0.0031
890 ERUCTATION 60 0.0031
891 INCORRECT PRODUCT ADMINISTRATION DURATION 67 0.0031
892 GASTROINTESTINAL HAEMORRHAGE 258 0.0031
893 JAUNDICE 83 0.0031
894 GLOSSODYNIA 69 0.0031
895 LACRIMATION INCREASED 93 0.0031
896 HOSPITALISATION 472 0.0031
897 STEVENS-JOHNSON SYNDROME 68 0.0031
898 DIABETES MELLITUS INADEQUATE CONTROL 54 0.0030
899 RESPIRATORY DISTRESS 84 0.0030
900 DYSGEUSIA 226 0.0030
901 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 77 0.0030
902 OCULAR HYPERAEMIA 141 0.0030
903 HEPATOTOXICITY 66 0.0030
904 PNEUMOTHORAX 47 0.0030
905 BASAL CELL CARCINOMA 46 0.0029
906 NEUTROPENIA 400 0.0029
907 PRODUCT DISPENSING ERROR 64 0.0029
908 INJECTION SITE PRURITUS 195 0.0029
909 THROMBOCYTOPENIA 325 0.0029
910 PERITONITIS 60 0.0029
911 DRUG EFFECT INCOMPLETE 105 0.0029
912 RASH ERYTHEMATOUS 138 0.0029
913 BONE DENSITY DECREASED 90 0.0029
914 PULMONARY FIBROSIS 55 0.0029
915 DRUG RESISTANCE 73 0.0028
916 DISABILITY 56 0.0028
917 INCORRECT DOSE ADMINISTERED 645 0.0028
918 CEREBROVASCULAR ACCIDENT 475 0.0028
919 ISCHAEMIC STROKE 50 0.0028
920 EMOTIONAL DISTRESS 339 0.0028
921 NEUTROPHIL COUNT DECREASED 114 0.0028
922 RECTAL HAEMORRHAGE 120 0.0028
923 NEOPLASM PROGRESSION 96 0.0028
924 DEEP VEIN THROMBOSIS 178 0.0027
925 FACE OEDEMA 46 0.0027
926 DISEASE PROGRESSION 322 0.0027
927 BLOOD GLUCOSE ABNORMAL 50 0.0027
928 CARDIAC FAILURE CONGESTIVE 217 0.0027
929 INTERNATIONAL NORMALISED RATIO INCREASED 77 0.0027
930 COLITIS ULCERATIVE 120 0.0027
931 INJECTION SITE MASS 99 0.0027
932 PRODUCT ADHESION ISSUE 95 0.0027
933 ACTIVITIES OF DAILY LIVING IMPAIRED 52 0.0026
934 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 532 0.0026
935 ERYTHEMA 538 0.0026
936 INJECTION SITE RASH 80 0.0026
937 SKIN CANCER 56 0.0026
938 DEAFNESS 68 0.0026
939 HYPOCALCAEMIA 49 0.0026
940 LABORATORY TEST ABNORMAL 76 0.0026
941 DEVICE ISSUE 230 0.0026
942 DRUG EFFECT DECREASED 138 0.0026
943 INJECTION SITE URTICARIA 62 0.0025
944 SHOCK 58 0.0025
945 INJECTION SITE PAIN 749 0.0024
946 BLOOD GLUCOSE INCREASED 458 0.0024
947 HAEMORRHAGE 253 0.0024
948 ILL-DEFINED DISORDER 147 0.0024
949 VAGINAL HAEMORRHAGE 105 0.0024
950 INJECTION SITE REACTION 165 0.0024
951 INJECTION SITE SWELLING 183 0.0024
952 CYTOKINE RELEASE SYNDROME 47 0.0023
953 DRUG DOSE OMISSION 387 0.0023
954 OSTEONECROSIS 76 0.0023
955 NEOPLASM MALIGNANT 153 0.0023
956 DEVICE DISLOCATION 99 0.0023
957 INJURY 158 0.0022
958 ACNE 170 0.0022
959 PANCYTOPENIA 123 0.0022
960 RASH MACULO-PAPULAR 48 0.0022
961 DRUG DEPENDENCE 342 0.0021
962 DEATH 1827 0.0021
963 MYOCARDIAL INFARCTION 363 0.0021
964 LUNG NEOPLASM MALIGNANT 85 0.0021
965 INJECTION SITE ERYTHEMA 252 0.0020
966 ADVERSE EVENT 185 0.0020
967 CORONARY ARTERY DISEASE 58 0.0019
968 ACCIDENTAL EXPOSURE TO PRODUCT 197 0.0019
969 VISUAL ACUITY REDUCED 63 0.0019
970 PREMATURE BABY 57 0.0019
971 DEVICE MALFUNCTION 133 0.0019
972 EXTRA DOSE ADMINISTERED 74 0.0018
973 FEBRILE NEUTROPENIA 121 0.0018
974 BLOOD BILIRUBIN INCREASED 49 0.0018
975 SKIN IRRITATION 83 0.0018
976 MALIGNANT NEOPLASM PROGRESSION 185 0.0018
977 APPLICATION SITE ERYTHEMA 45 0.0017
978 PRODUCT QUALITY ISSUE 231 0.0017
979 DEVICE DELIVERY SYSTEM ISSUE 46 0.0017
980 ASCITES 47 0.0016
981 EXPIRED PRODUCT ADMINISTERED 52 0.0016
982 DEVICE LEAKAGE 67 0.0015
983 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 72 0.0015
984 INJECTION SITE HAEMORRHAGE 122 0.0015
985 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 51 0.0015
986 SKIN BURNING SENSATION 101 0.0014
987 BREAST CANCER 119 0.0013
988 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 90 0.0013
989 NO ADVERSE EVENT 225 0.0012
990 DEVICE BREAKAGE 50 0.0012
991 PRODUCT STORAGE ERROR 97 0.0011
992 DEVICE DIFFICULT TO USE 67 0.0010
993 DRUG DOSE OMISSION BY DEVICE 77 0.0010